---
title: "Verapamil - Acute Coronary Syndrome"
sidebar: mydoc_sidebar
permalink: db00661-mesh-d054058-1.html
toc: false 
---


Path ID: `DB00661_MESH_D054058_1`
{% include image.html url="images/db00661-mesh-d054058-1.png" file="db00661-mesh-d054058-1.png" alt="db00661-mesh-d054058-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014700 | verapamil | Drug |
| InterPro:IPR005446 | Voltage-dependent calcium channel, L-type, alpha-1 subunit | GeneFamily |
| GO:0060402 | calcium ion transport into cytosol | BiologicalProcess |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| HP:0033401 | Tissue ischemia | PhenotypicFeature |
| MESH:D054058 | Acute coronary syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Verapamil | DECREASES ACTIVITY OF | Voltage-Dependent Calcium Channel, L-Type, Alpha-1 Subunit |
| Voltage-Dependent Calcium Channel, L-Type, Alpha-1 Subunit | POSITIVELY REGULATES | Calcium Ion Transport Into Cytosol |
| Calcium Ion Transport Into Cytosol | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Tissue Ischemia |
| Tissue Ischemia | POSITIVELY CORRELATED WITH | Acute Coronary Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00661#mechanism-of-action](https://go.drugbank.com/drugs/DB00661#mechanism-of-action)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL6966/)
  - [https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action](https://en.wikipedia.org/wiki/Verapamil#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents](https://en.wikipedia.org/wiki/Antiarrhythmic_agent#Class_IV_agents)
